drugset / Trial / NCT00251082
Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
RandomizedParallel-groupDouble-blindTreatment
Summary
To demonstrate efficacy of continuous combined 0.5 mg estradiol and 2.5 mg dydrogesterone versus placebo in the treatment of vasomotor symptoms after a treatment period of 3 months and to investigate the bleeding pattern over a treatment period of one year
Timeline
- Start
- 2005-12
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dydrogesterone | Other / unclassified | 2.5 mg | — |
| Comparator | Dydrogesterone | Other / unclassified | 5 mg | — |
| Comparator | Estradiol | Other / unclassified | 0.5 mg | — |
| Comparator | Estradiol | Other / unclassified | 1 mg | — |
Indications
No indication recorded.